Index by author
July 01, 2003; Volume 31,Issue 7
A
Allen, Christopher
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
Andrews, Robert C.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
B
Beattie, Iain G.
- You have accessCYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATIONRichard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. RileyDrug Metabolism and Disposition July 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Beaudet, Elizabeth J.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Becherer, J. David
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Billecke, Scott S.
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
Bjornsson, Thorir D.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Borlak, Jürgen
- You have accessVERAPAMIL: METABOLISM IN CULTURES OF PRIMARY HUMAN CORONARY ARTERIAL ENDOTHELIAL CELLSJürgen Borlak, Markus Walles, Karsten Levsen and Thomas ThumDrug Metabolism and Disposition July 2003, 31 (7) 888-891; DOI: https://doi.org/10.1124/dmd.31.7.888
Brodie, Thomas A.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Burka, L. T.
- You have accessCOMPARATIVE DISPOSITION OF (R)-(+)-PULEGONE IN B6C3F1 MICE AND F344 RATSL.-J. Chen, E. H. Lebetkin and L. T. BurkaDrug Metabolism and Disposition July 2003, 31 (7) 892-899; DOI: https://doi.org/10.1124/dmd.31.7.892
C
Callaghan, John T.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Cashman, John R.
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
Chen, Chuan
- You have accessNUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16α-CARBONITRILEChuan Chen, Jeff L. Staudinger and Curtis D. KlaassenDrug Metabolism and Disposition July 2003, 31 (7) 908-915; DOI: https://doi.org/10.1124/dmd.31.7.908
Chen, Jun
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Chen, L.-J.
- You have accessCOMPARATIVE DISPOSITION OF (R)-(+)-PULEGONE IN B6C3F1 MICE AND F344 RATSL.-J. Chen, E. H. Lebetkin and L. T. BurkaDrug Metabolism and Disposition July 2003, 31 (7) 892-899; DOI: https://doi.org/10.1124/dmd.31.7.892
Chiba, Kan
- You have accessSELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RATKaoru Kobayashi, Kikuko Urashima, Noriaki Shimada and Kan ChibaDrug Metabolism and Disposition July 2003, 31 (7) 833-836; DOI: https://doi.org/10.1124/dmd.31.7.833
D
Dabrowiak, James C.
- You have accessKINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEINDouglas Hagrman, Jerry Goodisman, James C. Dabrowiak and Abdul-Kader SouidDrug Metabolism and Disposition July 2003, 31 (7) 916-923; DOI: https://doi.org/10.1124/dmd.31.7.916
Dai, Renke
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Demady, Damon R.
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
Dunbar, Anwar Y.
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
E
Einolf, Heidi J.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Evans, David C.
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
Everett, Andrew C.
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
Evers, Raymond
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
F
Fischer, Volker
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Furnes, Bjarte
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
G
Gan, Lawrence
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Gaul, Michael D.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Ge, Xia
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Gedamke, Richard
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Gelboin, Harry L.
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Gonzalez, Frank. J.
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Goodisman, Jerry
- You have accessKINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEINDouglas Hagrman, Jerry Goodisman, James C. Dabrowiak and Abdul-Kader SouidDrug Metabolism and Disposition July 2003, 31 (7) 916-923; DOI: https://doi.org/10.1124/dmd.31.7.916
Graham, Ken S.
- You have accessCYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATIONRichard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. RileyDrug Metabolism and Disposition July 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Greenblatt, David J.
- You have accessIN VITRO METABOLISM OF MIDAZOLAM, TRIAZOLAM, NIFEDIPINE, AND TESTOSTERONE BY HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROMES P450: ROLE OF CYP3A4 AND CYP3A5Kiran C. Patki, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition July 2003, 31 (7) 938-944; DOI: https://doi.org/10.1124/dmd.31.7.938
Grimm, Scott
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
H
Hagrman, Douglas
- You have accessKINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEINDouglas Hagrman, Jerry Goodisman, James C. Dabrowiak and Abdul-Kader SouidDrug Metabolism and Disposition July 2003, 31 (7) 916-923; DOI: https://doi.org/10.1124/dmd.31.7.916
Hakk, Heldur
- You have accessDECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETIONAnna Mörck, Heldur Hakk, Ulrika Örn and Eva Klasson WehlerDrug Metabolism and Disposition July 2003, 31 (7) 900-907; DOI: https://doi.org/10.1124/dmd.31.7.900
Hamilton, Geraldine
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Hammock, Bruce D.
- You have accessIN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREATakaho Watanabe, Christophe Morisseau, John W. Newman and Bruce D. HammockDrug Metabolism and Disposition July 2003, 31 (7) 846-853; DOI: https://doi.org/10.1124/dmd.31.7.846
Hargreaves, Richard
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
Hoivik, Debie J.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Hu, Ming
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Hutzler, J. Matthew
- You have accessIN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESMichael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll and Larry C. WienkersDrug Metabolism and Disposition July 2003, 31 (7) 878-887; DOI: https://doi.org/10.1124/dmd.31.7.878
I
Ito, Kiyomi
- You have accessPREDICTION OF THE IN VIVO INTERACTION BETWEEN MIDAZOLAM AND MACROLIDES BASED ON IN VITRO STUDIES USING HUMAN LIVER MICROSOMESKiyomi Ito, Kanako Ogihara, Shin-ichi Kanamitsu and Tomoo ItohDrug Metabolism and Disposition July 2003, 31 (7) 945-954; DOI: https://doi.org/10.1124/dmd.31.7.945
Itoh, Tomoo
- You have accessPREDICTION OF THE IN VIVO INTERACTION BETWEEN MIDAZOLAM AND MACROLIDES BASED ON IN VITRO STUDIES USING HUMAN LIVER MICROSOMESKiyomi Ito, Kanako Ogihara, Shin-ichi Kanamitsu and Tomoo ItohDrug Metabolism and Disposition July 2003, 31 (7) 945-954; DOI: https://doi.org/10.1124/dmd.31.7.945
J
Jolley, Summer
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Jones, Jeffrey P.
- You have accessA NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVESCharles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. JonesDrug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
K
Kamada, Yasuhiko
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
Kanamitsu, Shin-ichi
- You have accessPREDICTION OF THE IN VIVO INTERACTION BETWEEN MIDAZOLAM AND MACROLIDES BASED ON IN VITRO STUDIES USING HUMAN LIVER MICROSOMESKiyomi Ito, Kanako Ogihara, Shin-ichi Kanamitsu and Tomoo ItohDrug Metabolism and Disposition July 2003, 31 (7) 945-954; DOI: https://doi.org/10.1124/dmd.31.7.945
Kao, John
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
King, S. Peter
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Klaassen, Curtis D.
- You have accessNUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16α-CARBONITRILEChuan Chen, Jeff L. Staudinger and Curtis D. KlaassenDrug Metabolism and Disposition July 2003, 31 (7) 908-915; DOI: https://doi.org/10.1124/dmd.31.7.908
Kliewer, Steven
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Klunk, Lewis
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Kobayashi, Kaoru
- You have accessSELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RATKaoru Kobayashi, Kikuko Urashima, Noriaki Shimada and Kan ChibaDrug Metabolism and Disposition July 2003, 31 (7) 833-836; DOI: https://doi.org/10.1124/dmd.31.7.833
Koets, Michael D.
- You have accessIN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESMichael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll and Larry C. WienkersDrug Metabolism and Disposition July 2003, 31 (7) 878-887; DOI: https://doi.org/10.1124/dmd.31.7.878
Krausz, Kristopher
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Kumar, Gondi
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
L
Laethem, Ron
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Lake, Brian G.
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
Lattard, Virginie
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
Lebetkin, E. H.
- You have accessCOMPARATIVE DISPOSITION OF (R)-(+)-PULEGONE IN B6C3F1 MICE AND F344 RATSL.-J. Chen, E. H. Lebetkin and L. T. BurkaDrug Metabolism and Disposition July 2003, 31 (7) 892-899; DOI: https://doi.org/10.1124/dmd.31.7.892
LeCluyse, Edward L.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Lehmann, Jurgen
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Levsen, Karsten
- You have accessVERAPAMIL: METABOLISM IN CULTURES OF PRIMARY HUMAN CORONARY ARTERIAL ENDOTHELIAL CELLSJürgen Borlak, Markus Walles, Karsten Levsen and Thomas ThumDrug Metabolism and Disposition July 2003, 31 (7) 888-891; DOI: https://doi.org/10.1124/dmd.31.7.888
Li, Jianqi
- You have accessIDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONESMing Hu, Kristopher Krausz, Jun Chen, Xia Ge, Jianqi Li, Harry L. Gelboin and Frank. J. GonzalezDrug Metabolism and Disposition July 2003, 31 (7) 924-931; DOI: https://doi.org/10.1124/dmd.31.7.924
Locuson, Charles W.
- You have accessA NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVESCharles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. JonesDrug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
Lowe, Ezra R.
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
M
McDougald, Darryl L.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
McLeod, James
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Mellon-Kusibab, Kathy
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Mitroka, James
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Miwa, Gerald
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Moore, Linda
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Mörck, Anna
- You have accessDECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETIONAnna Mörck, Heldur Hakk, Ulrika Örn and Eva Klasson WehlerDrug Metabolism and Disposition July 2003, 31 (7) 900-907; DOI: https://doi.org/10.1124/dmd.31.7.900
Morisseau, Christophe
- You have accessIN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREATakaho Watanabe, Christophe Morisseau, John W. Newman and Bruce D. HammockDrug Metabolism and Disposition July 2003, 31 (7) 846-853; DOI: https://doi.org/10.1124/dmd.31.7.846
N
Newman, John W.
- You have accessIN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREATakaho Watanabe, Christophe Morisseau, John W. Newman and Bruce D. HammockDrug Metabolism and Disposition July 2003, 31 (7) 846-853; DOI: https://doi.org/10.1124/dmd.31.7.846
Ni, Lan
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Novick, Steven
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
O
O'Connor, Desmond
- You have accessELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEINDavid C. Evans, Desmond O'Connor, Brian G. Lake, Raymond Evers, Christopher Allen and Richard HargreavesDrug Metabolism and Disposition July 2003, 31 (7) 861-869; DOI: https://doi.org/10.1124/dmd.31.7.861
Obach, R. Scott
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Ogan, Marc
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Ogihara, Kanako
- You have accessPREDICTION OF THE IN VIVO INTERACTION BETWEEN MIDAZOLAM AND MACROLIDES BASED ON IN VITRO STUDIES USING HUMAN LIVER MICROSOMESKiyomi Ito, Kanako Ogihara, Shin-ichi Kanamitsu and Tomoo ItohDrug Metabolism and Disposition July 2003, 31 (7) 945-954; DOI: https://doi.org/10.1124/dmd.31.7.945
Örn, Ulrika
- You have accessDECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETIONAnna Mörck, Heldur Hakk, Ulrika Örn and Eva Klasson WehlerDrug Metabolism and Disposition July 2003, 31 (7) 900-907; DOI: https://doi.org/10.1124/dmd.31.7.900
Osawa, Yoichi
- You have accessMETABOLISM-BASED INACTIVATION OF NEURONAL NITRIC-OXIDE SYNTHASE BY COMPONENTS OF CIGARETTE AND CIGARETTE SMOKEDamon R. Demady, Ezra R. Lowe, Andrew C. Everett, Scott S. Billecke, Yasuhiko Kamada, Anwar Y. Dunbar and Yoichi OsawaDrug Metabolism and Disposition July 2003, 31 (7) 932-937; DOI: https://doi.org/10.1124/dmd.31.7.932
P
Patki, Kiran C.
- You have accessIN VITRO METABOLISM OF MIDAZOLAM, TRIAZOLAM, NIFEDIPINE, AND TESTOSTERONE BY HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROMES P450: ROLE OF CYP3A4 AND CYP3A5Kiran C. Patki, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition July 2003, 31 (7) 938-944; DOI: https://doi.org/10.1124/dmd.31.7.938
Podoll, Terry
- You have accessIN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESMichael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll and Larry C. WienkersDrug Metabolism and Disposition July 2003, 31 (7) 878-887; DOI: https://doi.org/10.1124/dmd.31.7.878
R
Riley, Rob J.
- You have accessCYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATIONRichard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. RileyDrug Metabolism and Disposition July 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Rinehart, J. Kent
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Roberts, Stanley
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Rock, Dan A.
- You have accessA NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVESCharles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. JonesDrug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
Rock, Denise A.
- You have accessA NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVESCharles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. JonesDrug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
Roe, Amy
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Roongta, Vikram
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
S
Schlenk, Daniel
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
Shah, Anita
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Shimada, Noriaki
- You have accessSELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RATKaoru Kobayashi, Kikuko Urashima, Noriaki Shimada and Kan ChibaDrug Metabolism and Disposition July 2003, 31 (7) 833-836; DOI: https://doi.org/10.1124/dmd.31.7.833
Snikeris, Fred
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Souid, Abdul-Kader
- You have accessKINETIC STUDY ON THE REACTION OF CISPLATIN WITH METALLOTHIONEINDouglas Hagrman, Jerry Goodisman, James C. Dabrowiak and Abdul-Kader SouidDrug Metabolism and Disposition July 2003, 31 (7) 916-923; DOI: https://doi.org/10.1124/dmd.31.7.916
Staudinger, Jeff L.
- You have accessNUCLEAR RECEPTOR, PREGNANE X RECEPTOR, IS REQUIRED FOR INDUCTION OF UDP-GLUCURONOSYLTRANSFERASES IN MOUSE LIVER BY PREGNENOLONE-16α-CARBONITRILEChuan Chen, Jeff L. Staudinger and Curtis D. KlaassenDrug Metabolism and Disposition July 2003, 31 (7) 908-915; DOI: https://doi.org/10.1124/dmd.31.7.908
Sullivan, John T.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
T
Thum, Thomas
- You have accessVERAPAMIL: METABOLISM IN CULTURES OF PRIMARY HUMAN CORONARY ARTERIAL ENDOTHELIAL CELLSJürgen Borlak, Markus Walles, Karsten Levsen and Thomas ThumDrug Metabolism and Disposition July 2003, 31 (7) 888-891; DOI: https://doi.org/10.1124/dmd.31.7.888
Tippin, Timothy K.
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Tran, Quyen
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
Tweedie, Donald
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
U
Urashima, Kikuko
- You have accessSELECTIVITIES OF HUMAN CYTOCHROME P450 INHIBITORS TOWARD RAT P450 ISOFORMS: STUDY WITH cDNA-EXPRESSED SYSTEMS OF THE RATKaoru Kobayashi, Kikuko Urashima, Noriaki Shimada and Kan ChibaDrug Metabolism and Disposition July 2003, 31 (7) 833-836; DOI: https://doi.org/10.1124/dmd.31.7.833
V
Vega, Jose M.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
von Moltke, Lisa L.
- You have accessIN VITRO METABOLISM OF MIDAZOLAM, TRIAZOLAM, NIFEDIPINE, AND TESTOSTERONE BY HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROMES P450: ROLE OF CYP3A4 AND CYP3A5Kiran C. Patki, Lisa L. von Moltke and David J. GreenblattDrug Metabolism and Disposition July 2003, 31 (7) 938-944; DOI: https://doi.org/10.1124/dmd.31.7.938
W
Wahlstrom, Jan L.
- You have accessA NEW CLASS OF CYP2C9 INHIBITORS: PROBING 2C9 SPECIFICITY WITH HIGH-AFFINITY BENZBROMARONE DERIVATIVESCharles W. Locuson, Jan L. Wahlstrom, Denise A. Rock, Dan A. Rock and Jeffrey P. JonesDrug Metabolism and Disposition July 2003, 31 (7) 967-971; DOI: https://doi.org/10.1124/dmd.31.7.967
Walles, Markus
- You have accessVERAPAMIL: METABOLISM IN CULTURES OF PRIMARY HUMAN CORONARY ARTERIAL ENDOTHELIAL CELLSJürgen Borlak, Markus Walles, Karsten Levsen and Thomas ThumDrug Metabolism and Disposition July 2003, 31 (7) 888-891; DOI: https://doi.org/10.1124/dmd.31.7.888
Walsh, John
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Watanabe, Takaho
- You have accessIN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREATakaho Watanabe, Christophe Morisseau, John W. Newman and Bruce D. HammockDrug Metabolism and Disposition July 2003, 31 (7) 846-853; DOI: https://doi.org/10.1124/dmd.31.7.846
Weaver, Richard
- You have accessCYTOCHROME P450 INHIBITION USING RECOMBINANT PROTEINS AND MASS SPECTROMETRY/MULTIPLE REACTION MONITORING TECHNOLOGY IN A CASSETTE INCUBATIONRichard Weaver, Ken S. Graham, Iain G. Beattie and Rob J. RileyDrug Metabolism and Disposition July 2003, 31 (7) 955-966; DOI: https://doi.org/10.1124/dmd.31.7.955
Wehler, Eva Klasson
- You have accessDECABROMODIPHENYL ETHER IN THE RAT: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETIONAnna Mörck, Heldur Hakk, Ulrika Örn and Eva Klasson WehlerDrug Metabolism and Disposition July 2003, 31 (7) 900-907; DOI: https://doi.org/10.1124/dmd.31.7.900
Wienkers, Larry C.
- You have accessIN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESMichael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll and Larry C. WienkersDrug Metabolism and Disposition July 2003, 31 (7) 878-887; DOI: https://doi.org/10.1124/dmd.31.7.878
Wrighton, Steven A.
- You have accessTHE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEThorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, R. Scott Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh and Steven A. WrightonDrug Metabolism and Disposition July 2003, 31 (7) 815-832; DOI: https://doi.org/10.1124/dmd.31.7.815
Wynalda, Michael A.
- You have accessIN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMESMichael A. Wynalda, J. Matthew Hutzler, Michael D. Koets, Terry Podoll and Larry C. WienkersDrug Metabolism and Disposition July 2003, 31 (7) 878-887; DOI: https://doi.org/10.1124/dmd.31.7.878
Z
Zhang, Donglu
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837
Zhang, Jun
- You have accessTWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESVirginie Lattard, Jun Zhang, Quyen Tran, Bjarte Furnes, Daniel Schlenk and John R. CashmanDrug Metabolism and Disposition July 2003, 31 (7) 854-860; DOI: https://doi.org/10.1124/dmd.31.7.854
Zhao, Zhiyang
- You have accessCYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANSTimothy K. Tippin, Geraldine Hamilton, Linda Moore, Elizabeth J. Beaudet, Summer Jolley, Thomas A. Brodie, Robert C. Andrews, J. David Becherer, Darryl L. McDougald, Michael D. Gaul, Debie J. Hoivik, Kathy Mellon-Kusibab, Jurgen Lehmann, Steven Kliewer, Steven Novick, Ron Laethem, Zhiyang Zhao and Edward L. LeCluyseDrug Metabolism and Disposition July 2003, 31 (7) 870-877; DOI: https://doi.org/10.1124/dmd.31.7.870
Zhu, Mingshe
- You have accessPROTEIN COVALENT BINDING OF MAXIPOST THROUGH A CYTOCHROME P450-MEDIATED ORTHO-QUINONE METHIDE INTERMEDIATE IN RATSDonglu Zhang, Marc Ogan, Richard Gedamke, Vikram Roongta, Renke Dai, Mingshe Zhu, J. Kent Rinehart, Lewis Klunk and James MitrokaDrug Metabolism and Disposition July 2003, 31 (7) 837-845; DOI: https://doi.org/10.1124/dmd.31.7.837